Drugs / Norditropin SimpleXx
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy2 trials | ||||||
| Phase 1 | NCT01034202 Comparator | Aug 2007 → Jan 2008 | — | Novo Nordisk A/S | Completed | No outcome recorded |
| — | NCT00372125 Comparator | Apr 2005 → Mar 2010 | Prader-Willi syndrome | Karolinska University Hospital | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Norditropin SimpleXx | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01034202 ↗ |
| Route | Subcutaneous | “sc injections of GH (Norditropin Simplexx) in the evening” NCT00372125 ↗ |